United-Guardian, Inc. (UG) Stock

Consumer Defensive · Household & Personal Products · Member of Other US Stocks

United-Guardian, Inc. (UG) closed at USD 6.97 on 2026-10-14, a change of +3.4 % over the past year, with a market capitalization of USD 31.47M.

United-Guardian, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

United-Guardian, Inc. key figures

Previous close

USD 6.97 (2026-10-14)

1-year change

+3.4 %

Market cap

USD 31.47M

Enterprise value

USD 21.88M

P/E ratio (trailing)

12.69

P/E ratio (forward)

n/a

EPS (trailing)

0.54

EPS (forward)

n/a

PEG ratio

1.12

Price to book

2.71

Revenue growth

9.5 %

Earnings growth

16.2 %

Dividend per share (trailing)

0.40

Short ratio

1.48

Employees

23

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About United-Guardian, Inc.

United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil incorporates into a Lubrajel base. It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO. In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology. Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for United-Guardian, Inc. and compare it with other stocks.